Legislature
The Colorado Consortium for Prescription Drug Abuse Prevention works with the Colorado General Assembly to provide reliable information about the prescription drug use and misuse and prepare possible policies and regulations. That includes supporting the Opioid and Other Substance Use Disorder Interim Study Committee, a bipartisan panel of legislators that reviews data and helps develop potential bills.
As we do every year, the Consortium monitors the progress of the bills and kept stakeholders and members informed about new developments, including the hearing schedule and opportunities to testify.
If you would like to know more about the Legislative process, find helpful links, and learn more about testifying, please visit our post “All About the Legislature.”
2025 Session
Bills at a Glance
The General Assembly has returned for its 2025 session, and several bills related to substance use, behavioral health, and opioids are making their ways through various committees.
The Consortium follows many bills and attempts to keep our stakeholders updated. The Consortium has written a synopsis of the bills you can find on our blog. This is current as of Feb. 11.
The legislature’s website is the source for definitive information, including an up-to-date schedule and the latest amendments. Click the title of each bill to go to the relevant page.
- SB25-033 Prohibit New Liquor-Licensed Drug Stores
- SB25-042 Behavioral Health Crisis Response
- SB25-044 Synthetic Opiates Criminal Penalties
- SB25-066 State Contracts with Opioid Antagonist Businesses
- SB22-072 Regulation of Kratom
- SB25-076 Intoxicating Substances & Social Equity Business
- HB25-1002 Medical Necessity Determination Insurance Coverage
- HB25-1008 Complementary Behavioral Health Services in Jails
- HB25-1063 FDA-Approved Crystalline Polymorph Psilocybin Use